Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
At this concentration, a 500 mcg dose equals 0.2 mL (20 units on an insulin syringe)
Primary injection sites for AOD-9604 include the abdominal area (around the navel, varying position each injection), the front of the thighs (alternating legs), and the back of the upper arms (alternating arms)
TB-4 (full-length thymosin 4, 43 aa) Moves repair cells into position and biases healing toward functional tissue rather than rope-like scarring. GLOW uses the full-length TB-4 parent, not the shorter TB-500 fragment
This precaution helps prevent any unforeseen interactions and ensures safe use of the injection alongside other treatments
